Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | P4HB | P07237 | 1/20 | 0.48 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.48 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL230378 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL13435245 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL1527155 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL13461633 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL7028056 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL2786496 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL7028051 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL230379 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL16327524 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 | |
| SCHEMBL31180770 | 0.93 | TSHR (0.54) | TSHRLMNAP4HBPDIA4PDIA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015130890-A9 | SYNTHETIC SALT COMPLEXES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-29 | — | — | WO | disclosed |
| US-20150305333-A1 | USE OF GLUCOSAMINE AMIDES AS PLANT GROWTH AND YIELD ENHANCERS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| WO-2015130890-A1 | SYNTHETIC SALT COMPLEXES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-03 | — | — | WO | disclosed |
| WO-2015130893-A1 | SYNTHETIC OLIGOGLUCOSAMINES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-03 | — | — | WO | disclosed |
| US-9090644-B2 | Processes for chemical synthesis of lipochitooligosaccharides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-07-28 | — | — | US | disclosed |
| US-20140303361-A1 | PROCESSES FOR CHEMICAL SYNTHESIS OF LIPOCHITOOLIGOSACCHARIDES | DU PONT (US) | 2014-10-09 | — | — | US | disclosed |
| US-20120004401-A1 | COMPOSITIONS COMPRISING LIPOCHITOOLIGOSACCHARIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-05 | — | — | US | disclosed |
| US-8049002-B2 | Processes for chemical synthesis of lipochitooligosaccharides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-01 | — | — | US | disclosed |
| US-8049002-B2 | Processes for chemical synthesis of lipochitooligosaccharides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-01 | — | — | US | disclosed |
| US-20090292115-A1 | PROCESSES FOR CHEMICAL SYNTHESIS OF LIPOCHITOOLIGOSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090292115-A1 | PROCESSES FOR CHEMICAL SYNTHESIS OF LIPOCHITOOLIGOSACCHARIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-26 | — | — | US | disclosed |
| US-7485718-B2 | Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-03 | — | — | US | disclosed |
| US-20070238872-A1 | Processes for chemical synthesis of lipochitooligosaccharides | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-11 | — | — | US | disclosed |
| US-20070238872-A1 | Processes for chemical synthesis of lipochitooligosaccharides | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303361-A1 | PROCESSES FOR CHEMICAL SYNTHESIS OF LIPOCHITOOLIGOSACCHARIDES | PGLS, ALG1, DDOST | TSHR 4194/4885LMNA 1963/4885P4HB 2632/4885 |
| US-20150305333-A1 | USE OF GLUCOSAMINE AMIDES AS PLANT GROWTH AND YIELD ENHANCERS | NANS, UGCG, B3GNT2 | TSHR 2212/4885LMNA 1948/4885P4HB 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.